Depreciation in USD of Unicycive Therapeutics, Inc. from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to Q1 2025.
  • Unicycive Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $8K, a 11.1% decline year-over-year.
  • Unicycive Therapeutics, Inc. annual Depreciation for 2024 was $22K, a 144% increase from 2023.
  • Unicycive Therapeutics, Inc. annual Depreciation for 2023 was $9K, a 28.6% increase from 2022.
  • Unicycive Therapeutics, Inc. annual Depreciation for 2022 was $7K, a 600% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Unicycive Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $8K -$1K -11.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $9K +$7K +350% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $2K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $2K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-16

Unicycive Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $22K +$13K +144% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $9K +$2K +28.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $7K +$6K +600% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $1K -$62K -98.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $63K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.